Clinical Trial Results: Head and Neck Cancer

Home

Results

Protocol Registry

Trial Results

IFPMA

Background

Links

About this Registry

This database is populated with information on the results of Roche-sponsored clinical trials.

What are the differences between clinical trial phases?

Why has Roche decided to have its own registry and results database?

More FAQs

Glossary of Terms

Phase Definitions

Field Definitions

Clinical Trial Policy

Site Provided by Thomson CenterWatch

Clinical Trial Results: Head and Neck Cancer

Product Name: Tarceva [erlotinib]
Date of Report: To be Published
Phase: III
A Study of Tarceva (Erlotinib) in Patients With Resected Head and Neck Squamous Cell Cancer.

Product Name: Xeloda [capecitabine]
Date of Report: 7/26/2004
Phase: II
A dose-finding study of capecitabine (Ro 09-1978) in combination with standard radiotherapy in head and neck cancer patients


© 1996-2008 F.Hoffmann-La Roche Ltd See our legal Statement

Home

Trial Results updated: July 24, 2008 at 1:15:17 PM